Federal Circuit dissects Myriad arguments
The judges’ questioning in Association for Molecular Pathology v the USPTO and Myriad Genetics yesterday seemed to lean slightly in favour of Myriad, according to those attending the oral argument
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: